Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical Study: MEFDASE Study

NCT04288635 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT04288635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04288635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical Study: MEFDASE Study
Lead sponsor
University Hospital, Angers
Phase
Observational
Overall status
Recruiting
Start date
July 9, 2020
Completion date
August 9, 2027
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple organ failure, septic shock